These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19317379)

  • 1. Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia.
    Zammit G; Wang-Weigand S; Rosenthal M; Peng X
    J Clin Sleep Med; 2009 Feb; 5(1):34-40. PubMed ID: 19317379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
    Roth T; Seiden D; Wang-Weigand S; Zhang J
    Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
    Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
    Allain H; Bentué-Ferrer D; Tarral A; Gandon JM
    Eur J Clin Pharmacol; 2003 Jul; 59(3):179-88. PubMed ID: 12756510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects.
    Boyle J; Danjou P; Alexander R; Calder N; Gargano C; Agrawal N; Fu I; McCrea JB; Murphy MG
    Br J Clin Pharmacol; 2009 Feb; 67(2):180-90. PubMed ID: 19094161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
    Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference.
    Zammit G; Wang-Weigand S; Peng X
    BMC Geriatr; 2008 Jul; 8():15. PubMed ID: 18627623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.
    Kryger M; Wang-Weigand S; Roth T
    Sleep Breath; 2007 Sep; 11(3):159-64. PubMed ID: 17294232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ; Wang-Weigand S; Zhang J
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
    Zammit G; Erman M; Wang-Weigand S; Sainati S; Zhang J; Roth T
    J Clin Sleep Med; 2007 Aug; 3(5):495-504. PubMed ID: 17803013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.
    Kohsaka M; Kanemura T; Taniguchi M; Kuwahara H; Mikami A; Kamikawa K; Uno H; Ogawa A; Murasaki M; Sugita Y
    Expert Rev Neurother; 2011 Oct; 11(10):1389-97. PubMed ID: 21955196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
    Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
    Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening.
    Murphy P; Kumar D; Zammit G; Rosenberg R; Moline M
    J Clin Sleep Med; 2020 May; 16(5):765-773. PubMed ID: 32022664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
    J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.
    Gooneratne NS; Gehrman P; Gurubhagavatula I; Al-Shehabi E; Marie E; Schwab R
    J Clin Sleep Med; 2010 Dec; 6(6):572-80. PubMed ID: 21206546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.